Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)
a Department of
Pediatrics, b Department of Clinical Microbiology, c National University Hospital, Copenhagen,
Denmark Department of
Pharmacology and Pathobiology, The Royal Veterinary and Agricultural
University, Copenhagen, Denmark
Correspondence to: Dr M Skov, Center of Cystic Fibrosis 5003, Department of Pediatrics GGK, Juliane Marie Centre, National University Hospital, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.
Received 26 January 1998; Returned to authors 15 April 1998; Revised version received 6 July 1998; Accepted for publication 17 September 1998
BACKGROUND
IgG and IgG
subclass antibodies to Aspergillus fumigatus (A
fumigatus) were measured in a large population of patients with cystic fibrosis to elucidate a putative antibody pattern specific for
allergic bronchopulmonary aspergillosis (ABPA).
METHODS
An ELISA
technique using water soluble somatic hyphal (WSSH)
A fumigatus antigens and subclass specific monoclonal antibodies was used for cross sectional quantification of IgG and
IgG1-4 subclass antibody levels in the serum of 238 patients with cystic fibrosis and 107 healthy controls.
RESULTS
In patients
with cystic fibrosis persistently colonised with A
fumigatus the subclass antibody levels were significantly
increased compared with patients with cystic fibrosis never or rarely
colonised (p<0.001). The group of patients persistently colonised with
A fumigatus with ABPA (+Af+ABPA) had
significantly increased levels of IgG antibodies to
A fumigatus (Af-IgG) (median 69 ELISA units (EU) versus 31) and
of subclasses Af-IgG1 (91 versus 27), Af-IgG2 (143 versus 56), and Af-IgG4 antibodies (72 versus 20), but
not of IgG3 (17 versus 15), compared with the colonised
patients without ABPA (+Af-ABPA). Patients with cystic fibrosis with
no or only rare isolates of A fumigatus
without ABPA (-Af-ABPA) also had significantly increased
subclass antibody levels (Af-IgG1 9 versus 3, Af-IgG2 28 versus 5, Af-IgG4 16 versus 4;
p<0.001) compared with healthy controls. Low, although detectable,
levels of antibodies were demonstrated in healthy controls. ABPA seemed
to occur independently of Pseudomonas aeruginosa
infection. Using diagnostic cut off levels for ABPA, sensitivity
and specificity were calculated. The highest specificity was found for
IgG4 (88%); sensitivity was between 65% and 73%. The
positive predictive values (PPV) were moderate, whereas the negative
predictive values (NPV) were high (96% in all subclasses except
IgG3 with 94%). PPV increased to 50% if IgG1
as well as IgG2 and IgG4 were included.
CONCLUSIONS
In a large
number of unselected patients with cystic fibrosis significantly
increased levels of Af-specific antibodies belonging to total IgG and
all four subclasses were found in all groups of patients compared with
healthy controls. In patients persistently colonised with
A fumigatus these levels were significantly
higher than in non-colonised patients, and the significantly highest levels (with the exception of IgG3) were found in patients
with ABPA. Using a sensitive ELISA technique, measurements of IgG and IgG subclass antibodies to A fumigatus might
be of importance in the management of ABPA, especially as a screening
test to exclude the presence of ABPA; other tests are needed to confirm
the diagnosis.
© 1999 by Thorax
This article has been cited by other articles:
-
Latzin, P., Hartl, D., Regamey, N., Frey, U., Schoeni, M. H., Casaulta, C.
(2008). Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J
31: 36-42
[Abstract] [Full Text] -
Kraemer, R., Delosea, N., Ballinari, P., Gallati, S., Crameri, R.
(2006). Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
174: 1211-1220
[Abstract] [Full Text] -
Banerjee, B., Kelly, K. J., Fink, J. N., Henderson, J. D. Jr., Bansal, N. K., Kurup, V. P.
(2004). Modulation of Airway Inflammation by Immunostimulatory CpG Oligodeoxynucleotides in a Murine Model of Allergic Aspergillosis. Infect. Immun.
72: 6087-6094
[Abstract] [Full Text] -
Skov, M., Main, K.M., Sillesen, I.B., Muller, J., Koch, C., Lanng, S.
(2002). Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J
20: 127-133
[Abstract] [Full Text] -
Lyczak, J. B., Cannon, C. L., Pier, G. B.
(2002). Lung Infections Associated with Cystic Fibrosis. Clin. Microbiol. Rev.
15: 194-222
[Abstract] [Full Text] -
Mastella, G., Rainisio, M., Harms, H.K., Hodson, M.E., Koch, C., Navarro, J., Strandvik, B., McKenzie, S.G.
(2001). Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J
17: 1052-1053
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
